Work

High Dose Hyperfractionated Thoracic Radiotherapy vs. Standard Dose for Limited Stage Small-Cell Lung Cancer: A Multicenter, Open-Label Randomized, Phase 3 Trial

Year: 2023

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2023.06.205

Authors: J. Yu, L. Jiang, L. Zhao, X. Wang, X. Yang, D. Yang, M. Zhuo, H. Chen, Y.D. Zhao, F. Zhou, Q. Li, Z. Zhu, L. CHU, Z. Ma, Q. Wang, Y. Qu, W. Huang, M. Zhang, T. Gu, S. Liu, Y. Yang, J. Yang, H. Yu, R. Yu, J. Zhao, A. SHI

Institutions: Peking University Cancer Hospital, Xijing Hospital, Air Force Medical University, Anyang Tumor Hospital, Yuhuangding Hospital, Fudan University, Fudan University Shanghai Cancer Center, Chifeng Municipal Hospital, Sichuan Cancer Hospital, Liaoning Cancer Hospital & Institute, Shandong Tumor Hospital, Peking University, Peking University People's Hospital, Peking University First Hospital, First Hospital of Qinhuangdao, Jilin Province Tumor Hospital, First Affiliated Hospital of Xinxiang Medical University

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4387207622

FWCI: 0.241

Cites:

Cited by: 2

Related to: 10